We conducted searches using the following search terms: cisplatin, cancer, cisplatin nephrotoxicity, acute kidney injury, cisplatin-induced AKI, autophagy, AMPK-mTOR-mediated autophagy, necroptosis, RIPK1/RIPK3/MLKL-mediated necroptosis, necroinflammation, nephroprotective, autophagy activators, and necroptosis inhibitors
Discussion This review evaluates the effect on HR of six approved GLP-1 RAs, categorized into a short-acting sub-class with half-lives of 35 h (exenatide BID and lixisenatide) and a long-acting sub-class with half-lives ranging from 12 h to several days (liraglutide, exenatide LAR, albiglutide and dulaglutide) [16]
10.1097/TP.0b013e31820ae459 40 GustafsonE.AsifS.KozarcaninH.ElgueG.MeurlingS.EkdahlK
Establishment of culture systems of human gastric epithelium for the study of pepsinogen and gastric lipase synthesis and secretion
This might not be noticeable immediately, but it can affect your treatment over time